Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services crawled time : 20:20 save search
Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
Published: 2023-12-10 (Crawled : 20:20) - globenewswire.com
MOLN | $3.88 470
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
mp0533 first positive ongoing aml meeting trial molecular
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
TCRX | News 3 d | $7.235 1.62% 140K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
tsc-100 tsc-101 meeting therapeutics results
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
IPSC | $3.21 5.25% 36K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
cnty-101 trial therapeutics potential
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKIN
Published: 2023-11-26 (Crawled : 20:20) - prnewswire.com
SKIN | $3.32 1.53% 480K
|
Professional, Scientific, and T...
|
| O: -2.11%
H: 6.25%
C: 5.6%
SCYX | $1.56 8.33% 120K
|
Health Technology
|
| O: -1.2%
H: 3.66%
C: 0.61%
OTLK | News P | $8.3 2.6% 120K
|
Health Technology
|
| O: 1.07%
H: 3.68%
C: 1.57%
company health deadline beauty skin
Doximity, Inc. Investigation Notice: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Doximity, Inc. (NYSE: DOCS) Investors
Published: 2023-08-26 (Crawled : 20:20) - prnewswire.com
BTAI | News | $3.025 6.14% 300K
|
Health Technology
| Email alert
Add to watchlist
DOCS | $24.91 0.48% 490K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
Published: 2023-06-04 (Crawled : 20:20) - globenewswire.com
DAWN S | $17.28 12.35% 3.5M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
day101 day fda one submission
Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference
Published: 2023-01-08 (Crawled : 20:20) - globenewswire.com
MOLN | $3.88 470
|
Professional, Scientific, and T...
|
| O: 11.94%
H: 1.06%
C: -0.92%
conference molecular
Argentum 47, Inc. Releases Correction Statement Disclaiming Connection to AppleTV+ and BBC One
Published: 2022-12-17 (Crawled : 20:20) - globenewswire.com
ARGQ | $0.021 197.62% 5.5K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
one
Vera Therapeutics Reports Positive Interim Phase 2 Data Showing MAU868 Has Significant BK Antiviral Activity in Kidney Transplant Patients
Published: 2022-06-04 (Crawled : 20:20) - globenewswire.com
VERA | $40.87 4.45% 760K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
mau868 antiviral kidney therapeutics positive phase 2
ImmunoPrecise To Participate in BiotechGate Digital Partnering Event
Published: 2021-05-02 (Crawled : 20:20) - immunoprecise.com
IPA | $1.25 21K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
biotech iot
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.